TY - JOUR
T1 - Dynamic Analyses of the Short-Term Effects of Different Bisphosphonates Using Intravital Two-Photon Microscopy
AU - Kikuta, Junichi
AU - Shirazaki, Mai
AU - Sudo, Takao
AU - Mizuno, Hiroki
AU - Morimoto, Akito
AU - Suehara, Riko
AU - Minoshima, Masafumi
AU - Kikuchi, Kazuya
AU - Ishii, Masaru
N1 - Publisher Copyright:
© 2018 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
PY - 2018/11
Y1 - 2018/11
N2 - Bisphosphonates are commonly used for the treatment of bone disorders such as osteoporosis; however, the mechanism by which they affect the dynamics of living mature osteoclasts in vivo remains unknown. Here, we describe the short-term effects of different bisphosphonates on controlling the bone resorptive activity of mature osteoclasts in living bone tissues of mice using intravital two-photon microscopy with a pH-sensing chemical fluorescent probe. Three types of nitrogen-containing bisphosphonates, risedronate, alendronate, and minodronate, inhibited osteoclastic acidification during osteoporotic conditions just 12 hours after i.v. injection. Among the three types of drugs, risedronate was the most effective at increasing osteoclast motility and changing the localization of proton pumps, which led to an inhibition of bone resorption. Together, these results demonstrate that the intravital imaging system is a useful tool for evaluating the similarities and differences in currently used antibone resorptive drugs.
AB - Bisphosphonates are commonly used for the treatment of bone disorders such as osteoporosis; however, the mechanism by which they affect the dynamics of living mature osteoclasts in vivo remains unknown. Here, we describe the short-term effects of different bisphosphonates on controlling the bone resorptive activity of mature osteoclasts in living bone tissues of mice using intravital two-photon microscopy with a pH-sensing chemical fluorescent probe. Three types of nitrogen-containing bisphosphonates, risedronate, alendronate, and minodronate, inhibited osteoclastic acidification during osteoporotic conditions just 12 hours after i.v. injection. Among the three types of drugs, risedronate was the most effective at increasing osteoclast motility and changing the localization of proton pumps, which led to an inhibition of bone resorption. Together, these results demonstrate that the intravital imaging system is a useful tool for evaluating the similarities and differences in currently used antibone resorptive drugs.
UR - http://www.scopus.com/inward/record.url?scp=85068030628&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068030628&partnerID=8YFLogxK
U2 - 10.1002/jbm4.10057
DO - 10.1002/jbm4.10057
M3 - Article
AN - SCOPUS:85068030628
SN - 2473-4039
VL - 2
SP - 362
EP - 366
JO - JBMR Plus
JF - JBMR Plus
IS - 6
ER -